Circulating Progenitor Cells and Childhood Cardiovascular Disease
Related Experiment Video
Updated: Mar 30, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
Published on: January 7, 2019
Eric J Kort1,2,3, Lacey Croskey4, Taryn Scibienski4
1DeVos Cardiovascular Research Program of Spectrum Health and Van Andel Research Institute, 100 Michigan Street NE, Grand Rapids, MI, 49503, USA. eric.kort@vai.org.
Insights
Research on circulating progenitor cells in adult heart disease is extensive. However, studies in children with cardiovascular disease are limited, highlighting a need for further investigation into their role and therapeutic potential.
Area of Science:
- Cardiovascular Research
- Cellular Biology
- Pediatric Medicine
Background:
- Circulating progenitor cells are well-studied in adult myocardial injury and recovery.
- These cells show potential as therapeutic agents in adult cardiovascular disease.
- Knowledge regarding progenitor cells in pediatric cardiovascular disease remains limited.
Purpose of the Study:
- To review current knowledge on circulating progenitor cells in childhood cardiovascular disease.
- To identify research gaps and future directions in this field.
Main Methods:
- Literature review of existing studies on circulating progenitor cells in pediatric cardiovascular disease.
Main Results:
- Limited studies currently exist on circulating progenitor cells in children.
- The role and therapeutic potential of these cells in pediatric cardiovascular conditions are not well-defined.
Conclusions:
- Further research is urgently needed to understand circulating progenitor cells in childhood cardiovascular disease.
- Establishing the significance of these cells could lead to novel diagnostic and therapeutic strategies for pediatric heart conditions.
Abstract:
Circulating progenitor cells have been extensively studied in the context of heart disease in adults. In these patients, they have been demonstrated to be markers of myocardial injury and recovery as well as potential therapeutic agents. However, studies in children are much more limited. Here we review current knowledge pertaining to circulating progenitor cells in the context of childhood cardiovascular disease. Priorities for further research are also highlighted.
More Related Videos
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Production of Formed Elements
Most HSCs commit to...
Hematopoiesis
Regulation of Hematopoietic Stem Cells
Differentiation of Common Myeloid Progenitor Cells
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...

